Results 161 to 170 of about 834,111 (218)
Some of the next articles are maybe not open access.

Infant Botulism

Southern Medical Journal, 1981
The work of Thompson et al1 presents findings in nine Utah patients with infant botulism. In contrast to several other authorities who failed to demonstrate Botulobacillas botulinus in infants of the same age without evidence of clinical disease, Thompson et al1 report a significant number of positive stool cultures in infants who showed no evidence of
R A, Broughton, J, Campbell, H D, Wilson
  +13 more sources

Infant Botulism

Archives of Pediatrics & Adolescent Medicine, 1979
Infant botulism is a unique neuromuscular disease affecting infants less than six months old. It is the result of intraintestinal toxin production by C. botulinum (toxi-infection). Characteristic symptoms include constipation, lethargy, and decreased feeding.
R D, Snyder, J M, Bicknell
  +7 more sources

Infant botulism: an underestimated threat

Infectious Diseases, 2021
Infant botulism (IB) is defined as a potentially life-threatening neuroparalytic disorder affecting children younger than 12 months. It is caused by ingestion of food or dust contaminated by Clostridium botulinum spores, which germinate in the infant’s ...
Luca Antonucci   +4 more
semanticscholar   +1 more source

Comparative whole-genome sequence analysis of a BoNT/B5-producing Clostridium botulinum isolate from an infant botulism case of unknown source in Osaka, Japan.

FEMS Microbiology Letters, 2022
A case of infant botulism of unknown origin, not involved in honey consumption, occurred in Osaka, Japan in 2020. A Clostridium botulinum type B strain named Osaka2020 was isolated from a stool sample of the patient.
Kaoru Umeda   +3 more
semanticscholar   +1 more source

Global Occurrence of Infant Botulism: 2007-2021.

Pediatrics
We sought to summarize the worldwide occurrence and epidemiology of infant botulism (IB) from 2007 to 2021. Data were collected through active and passive surveillance, via hospital inquiries to the Infant Botulism Treatment and Prevention Program ...
H. Dabritz   +3 more
semanticscholar   +1 more source

International Experience with Human Botulism Immune Globulin for the Treatment of Infant Botulism

Medical Research Archives
Background: Human Botulism Immune Globulin Intravenous (BIG-IV) was licensed in the United States in October 2003 for the treatment of the rare, life-threatening infectious disease, infant botulism (IB) due to botulinum toxin types A or B.
Ashley Scarborough   +4 more
semanticscholar   +1 more source

Infant Botulism

Pediatrics In Review, 1996
Infant botulism was first described in 1976. It is caused by Clostridium botulinum, a gram-positive anaerobic bacillus found most commonly in soil and agricultural products. The organism forms spores and during growth and germination releases a potent neurotoxin that is responsible for the illness.
openaire   +2 more sources

6-month old with new-onset weakness – consider infant botulism

Archives of Disease in Childhood, 2021
A 6monthold boy with normal development developed constipation, poor feeding and lethargy, then drooping of the eyelids, weak cry, head lag and limb weakness. He had normal septic and metabolic workup and neuroimaging studies.
Luisa Angel Buitrago, P. Ghosh
semanticscholar   +1 more source

Dry and dusty outback: infant botulism

BMJ Case Reports
Infant botulism is a rare but life-threatening neuroparalytic syndrome caused by intestinal colonisation of Clostridium botulinum resulting in a symmetrical descending flaccid paralysis.
Patricia Grant   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy